Oxidative stress in drug naïve first episode psychosis and antioxidant effects of risperidone
- 1 September 2015
- journal article
- research article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 68, 210-216
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Antioxidants as potential therapeutics for neuropsychiatric disordersProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2013
- Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapyBreast Cancer Research and Treatment, 2011
- Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studiesInternational Journal of Neuropsychopharmacology, 2011
- A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illnessProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
- Oxidative stress in schizophrenia: An integrated approachNeuroscience & Biobehavioral Reviews, 2011
- Brain Anatomical Abnormalities in High-Risk Individuals, First-Episode, and Chronic Schizophrenia: An Activation Likelihood Estimation Meta-analysis of Illness ProgressionSchizophrenia Bulletin, 2009
- Modifications of blood platelet proteins of patients with schizophreniaPlatelets, 2009
- Definitions of response and remission in schizophrenia: recommendations for their use and their presentationActa Psychiatrica Scandinavica, 2008
- Determination of Paraoxonase 1 Status Without the Use of Toxic Organophosphate SubstratesCirculation: Cardiovascular Genetics, 2008
- Validity study of the Brazilian version of the Calgary Depression Scale for SchizophreniaSchizophrenia Research, 1998